Jean-Marc SABATIER is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He headed several academic research teams (CNRS, INSERM and University), as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins and microbes. He is the Editor-in-Chief of ‘Venoms and Toxins’, ‘Coronaviruses’, and ‘Infectious Disorders - Drug Targets’. He is also Topic Editor-in-Chief for ‘Antibiotics’. He so far contributed to several books in toxinology and virology, and more than 170 scientific articles, 180 communications, and 55 patents in both biology and chemistry. He is a member of 61 Editorial Boards of scientific journals, such as ‘Peptides’, ‘Molecules’, ‘Antibiotics’, and the ‘Journal of Biological chemistry’. He also reviewed articles submitted for publication in 101 international journals and acts as an expert for numerous institutions (ANR, CEA, CNRS, MRC, ISF, BARD, AIRD, IPT, Pasteur Institutes, Ville de Paris, Region Languedoc-Roussillon, Fondation Arthritis, etc.). He won the ‘Citizen of the Year Award’ from the Nouvel Economiste (1994) for his work on antivirals. He is a member of a dozen scientific societies, such as the ‘American Peptide Society’ (charter member), ‘European Peptide Society’, ‘American Society for Microbiology’, ‘Biochemical Society’ and ‘New-York Academy of Sciences’.